Collectively, the lower IL-6 levels associated with higher PGE2 and TNFRSF1a levels suggest that non-PASC patients may present a diminished inflammatory response instead of increased classical cytokines related to low-grade inflammation. This evidence concerns the gene IL6 and long COVID-19.